Stoke Therapeutics Inc buy Credit Suisse Group AG
Start price
08.08.23
/
50%
€4.88
Target price
08.08.24
€21.00
Performance (%)
162.30%
End price
09.08.24
€12.80
Summary
This prediction ended on 09.08.24 with a price of €12.80. With a performance of 162.30% the BUY prediction by Credit_Suisse_Group_ was a big success. Credit_Suisse_Group_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Stoke Therapeutics Inc | -9.353% | -9.353% | 186.364% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% |
Comments by Credit_Suisse_Group_ for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $23.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
In the thread Trading Stoke Therapeutics Inc
Die von Credit_Suisse_Group_ gewählte maximale Laufzeit wurde überschritten